Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation

Contraception

Volumn 70, Issue 6, 2004, Pages 442-450

  Croxatto, H B ^a   Brache, V ^b   Pavez, M ^a   Cochon, L ^b   Forcelledo, M L ^a   Alvarez, F ^b   Massai, R ^a   Faundes, A ^b   Salvatierra, A M ^a  

^a Instituto Chileno de Medicina Reproductiva   (Chile)

^b PROFAMILIA   (Dominican Republic)

Author keywords

Emergency contraception; Levonorgestrel; Ovarian function

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LEVONORGESTREL; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOLLICULAR PHASE; HEADACHE; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS FUNCTION; MENSTRUAL CYCLE; MULTICENTER STUDY; NORMAL HUMAN; OVARY FUNCTION; OVULATION; OVULATION INDUCTION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOMNOLENCE; STOMACH PAIN; TRANSVAGINAL ECHOGRAPHY;

ADOLESCENT; ADULT; CHILE; CONTRACEPTIVES, ORAL, SYNTHETIC; CONTRACEPTIVES, POSTCOITAL, SYNTHETIC; DOMINICAN REPUBLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LEVONORGESTREL; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OVARIAN FOLLICLE; OVULATION;

EID: 8444223215     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.05.007     Document Type: Article

References (35)

1. A.A. Yuzpe, H.J. Thurlow, I. Ramzy, and J.I. Leyshon Post coital contraception: a pilot study J. Reprod. Med. 13 1974 53 58
2. P.C. Ho, and M.S. Kwan A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception Hum. Reprod. 8 1993 389 392
3. Task Force on Postovulatory Methods of Fertility Regulation Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception Lancet 352 1998 428 433
4. Consensus statement of emergency contraception Contraception 52 1995 211 213
5. A.J. Wilcox, C.R. Weinberg, and D.D. Baird Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy and sex of the baby N. Engl. J. Med. 333 1995 1517 1521
6. H.B. Croxatto, B. Fuentealba, and V. Brache Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function Contraception 65 2002 121 128
7. H.B. Croxatto, L Devoto, and M Durand Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature Contraception 63 2001 111 121
8. H.B. Croxatto Response to letter from Rafael T Mikolajczyk and Joseph B Stanford Contraception 67 2003 335 337
9. J.F. Kerin, C. Kirby, and D. Morris Incidence of the luteinized unruptured follicle phenomenon in cycling women Fertil. Steril. 40 1983 620 626
10. H. Von Hertzen, G. Piaggio, and J. Ding Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial Lancet 360 2002 1803 1810
11. A.O. Arowojolu, I.A. Okewole, and A.O. Adekunle Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians Contraception 66 2002 269 273
12. D. Hapangama, A.F. Glasier, and D.T. Baird The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle Contraception 63 2001 123 129
13. M. Durand, M.C. Cravioto, and E.G. Raymond On the mechanism of action of short-term levonorgestrel administration in emergency contraception Contraception 64 2001 227 234
14. L. Marions, K. Hultenby, and I. Lindell Emergency contraception with mifepristone and levonorgestrel: mechanism of action Obstet. Gynecol. 100 2002 65 71
15. J. Eppig Regulation of mammmalian oocyte maturation E.Y. Adashi P.C.K. Leung The ovary 1993 Raven Press New York 185 208
16. A. Salustri, V.C. Hascall, A. Camaioni, and M. Yanagishita Oocyte-granulosa cell interactions E.Y. Adashi P.C.K. Leung The ovary 1993 Raven Press New York 209 225
17. L.L. Espey, and H. Lipner Ovulation E. Knobil J.D. Neill The physiology of reproduction 1994 Raven Press New York 725 780
18. S.M. Downs Ovulation 2: control of the resumption of meiotic maturation in mammalian oocytes J.G. Grudzinskas J.L. Yovich Cambridge reviews in human reproduction. Gametes-the oocyte 1995 Cambridge University Press Cambridge, UK 150 192
19. A. Tsafriri, and S.-Y. Chun Ovulation E.Y. Adashi J.A. Rock Z. Rosenwaks Reproductive endocrinology, surgery and technology 1996 Lippincott-Raven Publishers Philadelphia 385 402
20. B.J. Cohlen, E.R. te Velde, and G. Scheffer The pattern of the luteinizing hormone surge in spontaneous cycles is related to the probability of conception Fertil. Steril. 60 1993 413 417
21. C.B. Coulam, M. Bustillo, and J.D. Schulman Empty follicle syndrome Fertil. Steril. 46 1986 1153 1155
22. C.J. Quintans, M.J. Donaldson, L.A. Blanco, and RS. Pasqualini Empty follicle syndrome due to human errors: its occurrence in an in-vitro fertilization programme Hum. Reprod. 13 1998 2703 2705
23. F. Zegers-Hochschild, E. Fernandez, A. Mackenna, C. Fabres, E. Altieri, and T. Lopez The empty follicle syndrome: a pharmaceutical industry syndrome Hum. Reprod. 10 1995 2262 2265
24. G. Ndukwe, S. Thornton, S. Fishel, K. Dowell, M. Aloum, and S. Green 'Curing' empty follicle syndrome Hum. Reprod. 12 1997 21 23
25. F. Lok, J. Pritchard, and H. Lashen Successful treatment of empty follicle syndrome by triggering endogenous LH surge using GnRH agonist in an antagonist down-regulated IVF cycle Hum. Reprod. 18 2003 2079 2081
26. G.I. Meniru, and I.L. Craft Evidence from a salvaged treatment cycle supports an aetiology for the empty follicle syndrome that is related to terminal follicular developmental events Hum. Reprod. 12 1997 2385 2387
27. H.I. Abdalla, M. Ah-Moye, P. Brinsden, D.L. Howe, F. Okonofua, and I. Craft The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program Fertil. Steril. 48 1987 958 963
28. W.M. Verpoest, D.J. Cahill, C.R. Harlow, and MG. Hull Relationship between midcycle luteinizing hormone surge quality and oocyte fertilization Fertil. Steril. 73 2000 75 77
29. A.L. Müller, C.M. Llados, and HB. Croxatto Post-coital treatment with levonorgestrel does not disrupt post-fertilization events in the rat Contraception 67 2003 415 419
30. M.E. Ortiz, R.E. Ortiz, M.A. Fuentes, V.H. Parraguez, and H.B. Croxatto Post-coital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella Hum. Reprod. 19 2004 1352 1356
31. Y.E. Shi, S.H. Zheng, Y.H. Zhu, C.H. He, P.P. Yu, and K. Fotherby Pharmacokinetic study of levonorgestrel used as a postcoital agent Contraception 37 1988 359 369
32. C.H. He, Y.E. Shi, and D.L. Liao Comparative cross-over pharmacokinetic study on two types of postcoital contraceptive tablets containing levonorgestrel Contraception 41 1990 557 567
33. D. Tremblay, E. Gainer, and A. Ulmann The pharmacokinetics of 750 microgram levonorgestrel following administration of one single dose or two doses at 12- or 24-h interval Contraception 64 2001 327 331
34. K. Kook, H. Gabelnick, and C. Duncan Pharmacokinetics of levonorgestrel 0.75 tablets Contraception 66 2002 73 76
35. E. Johansson, V. Brache, and F. Alvarez Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women Hum. Reprod. 17 2002 1472 1476